Tj-m2010-5, a novel cns drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the myd88/nf- and erk pathway

HIGHLIGHTS

• who: TJ-M and collaborators from the Sichuan University, China have published the Article: TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF- and ERK pathway, in the Journal: (JOURNAL)
• what: The authors focused on the anti-neuroinflammatory effect of TJ-5. The authors evaluated the neuroprotective effects of TJ-5 in both Frontiers in Pharmacology h frontiersin.org 10.3389/fphar.2022.1080438 and IL-6 in the infarction areas after 24 h of reperfusion, suggesting that TJ-5 may interrupt the inflammatory cascade and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.